n.— «With biogenerics, you would have to show that the two biologics, made using different processes, contain the same ingredient. Then, you would have to prove that the two products are bioequivalent, especially when analytical methodology often does not exist or is proprietary to the brand name product. This would be quite difficult absent clinical studies.» —“FDA Chief: Biogenerics will be Similar, Not Interchangeable” by Stephen Albainy-Jenei Patent Baristas Mar. 26, 2007. (source: Double-Tongued Dictionary)

Tagged with →  

This site uses Akismet to reduce spam. Learn how your comment data is processed.